clioquinol and myelin oligodendrocyte glycoprotein (35-55)

clioquinol has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, BY; Chung, TN; Jang, BG; Kim, JH; Seo, JN; Sohn, M; Suh, SW; Wu, G	1

Other Studies

1 other study(ies) available for clioquinol and myelin oligodendrocyte glycoprotein (35-55)

Article	Year
Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model. Neurobiology of disease, 2013, Volume: 54 Topics: Animals; Axons; Behavior, Animal; Blotting, Western; Chelating Agents; Clioquinol; Copper; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Spinal Cord; Zinc	2013

Article

Year

Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model.

Neurobiology of disease, 2013, Volume: 54

Topics: Animals; Axons; Behavior, Animal; Blotting, Western; Chelating Agents; Clioquinol; Copper; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Spinal Cord; Zinc

2013